According to a study presented at the American Heart Association Scientific Sessions of.

Our opinionnvasive procedure safe alternative for the treatment of children with congenital heart defectsA less invasive procedure for the treatment of congenital heart disease in children is a safe alternative to traditional surgery without a five-year difference in the risk of death and a 62 % associated with lower risk for neurologic events , according to a study presented at the American Heart Association Scientific Sessions of.

The average age for surgical patients was 4.6 years compared with 5.7 years for transcatheter patients. The researchers found:.

Is evaluated in a study of 580 children with secundum atrial septal defect , researchers, the long-term safety and efficacy of transcatheter closure compared to conventional surgery. Transcatheter closure is a minimally invasive treatment for patients with uncomplicated ASD. – ‘In our opinion, the main advantage of transcatheter closure versus surgical closure is that it avoids the need for open heart surgery and thus the need for cardiopulmonary bypass,’said Colum Owens, study lead author and Adult Congenital Heart Disease Fellow at the MAUDE unit the Royal Victoria Hospital, McGill University Health Centre in Montreal..If set for the functionality and disease activity at follow-up, together with the Quite risk factors, of contributions from anti-TNF therapy for heart failure risk was low. The small residue risk the effectiveness of treatment the effectiveness of treatment reducing inflammation, ultimately the heart and other vital organs addition to to protect the joints. In contrast, COX – 2 inhibitors and glucocorticoids, elevated blood pressure an elevated blood pressure and insulin resistance, risk of cardiac diseases risk of heart disease and heart attacks.

Finally, he urges caution when prescription of drugs be hazardous to the be dangerous for the heart of a patients at risk. ‘screening of on cardiac risk factors and effective treatment which either rheumatic disease , and heart disease is essential,’stresses listing for.. ####articles:? If Tumour necrosis factor of encouraging O preventing prevent heart failure patients with rheumatoid arthritis Joachim Zapping, Anja Strangfeld, J r n Kekow, Matthias Schneider, Andreas Chapel, Siegfried Wassenberg and Angela tine, Arthritis & Rheumatism, March 2008.

Validate the grave of risk of heart failure of patients from severe rheumatoid arthritis, particularly those highly active disease, this trial also shed light on the benefits of treatment with TNF antagonists to the heart and the whole body.